cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells

Journal of Cell Science

Volumn 111, Issue 5, 1998, Pages 637-644

  Garcia Bermejo, Laura ^a,b   Pérez, Concepción ^c   Vilaboa, Nuria E ^a,d   De Blas, Elena ^a   Aller, Patricio ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; cAMP; Etoposide; U 937 promonocytic cells

Indexed keywords

CADMIUM CHLORIDE; CAMPTOTHECIN; CYCLIC AMP; ETOPOSIDE; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; RETINOBLASTOMA PROTEIN; THEOPHYLLINE;

APOPTOSIS; ARTICLE; CHROMATIN STRUCTURE; DEPHOSPHORYLATION; DNA DEGRADATION; DNA STRAND BREAKAGE; HEAT SHOCK; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE; ONCOGENE C MYC; PRIORITY JOURNAL; X IRRADIATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CYCLIC AMP; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 2642697857     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Barry. M. A., Reynolds, J. K. and Eastman, A. (1993). Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res. 53, 2349-2357
2. Bertrand, R., Sarang. M., Jenkin, J., Kerrigan, D. and Pommier, Y. (1991). Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res. 51, 6280-6285.
3. Bertrand, R., Solary. E., Jenkins. J., and Pommier, Y. (1993). Apoptosis and its modulation in human promyelocytic cells treated with DNA topoisomerase I and II inhibitors Exp. Cell. Res. 207, 388-397.
4. Bessho, R., Matsubara, K., Kubota, M., Kuwakado, K., Hirota, H., Wakazono, Y., Lin, Y. W., Okuda, A., Kawai, M., Nishikomori, R. and Heike, T. (1994). Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 48, 1883-1889.
5. Buquet-Fagot. C., Lallemand. F., Charollais, R.H. and Mester, J. (1996). Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fihroblasts by a transcription-dependent mechanism. J. Cell. Physiol. 166, 631-636.
6. Cotter, T. G., Fernandes, R. S., Verhaegen, S. and McCarthey, J. V. (1994). Cell death in the myeloid lineage. Immunol. Rev. 142, 93-112.
7. Chen, M., Quintans, J., Fuks, Z., Thompson, C., Kufe, D. W. and Weichselbaum, R. R. (1995). Suppression of Bcl-2 messenger RNA production may mediate apoptosis after radiation, tumor necrosis factor α and ceramide. Cancer Res. 55, 991-994.
8. D'Arpa, P. and Liu, L. F. (1989). Topoisomerase-targeting antitumour drugs. Biochim. Biophys. Acta 989, 163-167.
9. Dalla Favera, R., Gelman, E. P., Martinotti, S., Franchini, G., Papas, T., Gallo, R. C. and Wong-Staal, F. (1982). Cloning and characterization of different human sequences related to the one gene (v-myc) of avian myelocytomatosis virus (MC29). Proc. Nat. Acad. Sci. USA 79, 6497-6501.
10. Deckwerth, T. L. and Johnson, E. M. (1993). Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123, 1207-1222.
11. Dou, Q. P., An, B. and Will, P. L. (1995). Induction of a retinoblastoma phophatase activity by anticancer drugs accompanies p53-independent G 1 arrest and apoptosis. Proc. Nat. Acad. Sci. USA 92, 9019-9023.
12. Gardner, A., Xu, F. H., Fady, C., Sarafian, T., Tu, Y. and Lichtenstein, A. (1997). Evidence against the hypothesis that BCL-2 inhibits apoptosis through an anti-oxidant effect Cell Death Differ. 4, 487-496.
13. + T lymphoblasts. J. Immunol. 154, 1041-1047.
14. Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneman, V. E. A., Longthorne, V. L., Culhane, A. C. and Williams, G, T. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236, 1-26.
15. Harrington, E. A., Fanidi, A. and Evan, G. I. (1994). Oncogenes and cell death. Curr. Opin. Genet. Dev. 4, 120-129.
16. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L. and Korsmeyer, S. J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
17. Jänicke, R. E., Lee, F. H. H. and Porter, A. G. (1994). Nuclear c-myc plays an important role in the cytotoxicity of tumour necrosis factor alpha in tumour cells. Mol. Cell. Biol. 14, 5661-5670.
18. Karin, M., Liu, Z. G. and Zandi, E. (1997). AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246.
19. Kim, R. and Beck, W. T. (1994). Differences between drug-sensitive and resistant human leukcmic CEM cells in c-jun expression, AP-1 DNA binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Cancer Res. 54, 4958-4966.
20. Kizaki, H., Suzuki, K., Tadakuma, T, and Ishimura, Y. (1990). Adenosine receptor-mediated accumulation of cyclic AMP-induccd T-lymphocytc death through internucleosomal DNA cleavage. J. Biol. Chem. 265, 5280-5284.
21. + antiporter in murine macrophages. Biochem. Biophys. Res. Commun. 165, 131-137.
22. Lanotte, M., Riviere, J. B., Hermouet, S., Houge, G., Vinterrnir, O. K., Gjertsen, B. Y. and Doskeland, S. O. (1991). Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J. Cell. Physiol. 146, 73-80.
23. Lee, M. R., Liou, M. L., Liou, M. L., Yang, Y. F. and Lai, M. Z. (1993). cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. J. Immunol. 151, 5208-5217.
24. 2+ are not required to trigger apoptosis in human leukemia cells. Clin. Exp. Immunol. 87, 465-471.
25. Lotem, J. and Sachs, L. (1994). Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bol-2 dependent and independent pathways. Cell Growth Differ. 5, 321-327
26. McConkey. D. J., Orrenius, S., Okret, S. and Jondal. M. (1993) Cylic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes. FASEB J. 7, 580-585.
27. McGowan, A. J., Ruiz-Ruiz. M. C., Gorrnan. A. M., López-Rivas, A. an Cotter, T. G. (1996). Reactive oxygen intermediate(s) (ROI): Common mcdiator(s) of poly(ADP-ribose)polymerase (PARP) cleavage an apoptosis. FEBS LETT. 392, 299-303
28. Mesner, P. W., Budijardo, I. I. and Kaumann, S. H. (1997).Chemotherapy-induced apoptosis. In Apoptosis: Pharmacological. Implications and Therapeutic Opptortunities (ed. S. Kauffmann). pp. 461-499. Academic Press. San Diego, London. Boston. New York. Sydney Tokyo, Toronto.
29. Miner, A. E., Grand, R. J., Waters, C. M. and Gregory, C. D. (1993). Apoptosis in Burkitt lymphoma cells driven by c-myc. Oncogene 8, 3385-3391
30. Morana, S. J., Wolf, C. M., Li, J., Reynolds, J. E., Brown, M. K. and Eastman, A. (1996). The involvement of protein phosphatases in the activation of ICE/CED-3 proteases, intracellular acidification. DNA digestion and apoptosis. J. Biol. Chem. 271, 18263-18271.
31. Pérez, C., Vilaboa, N. E. and Aller, P. (1994). Etoposide-induced differentiation of U937 promonocytic cells: AP-1-dependent gene expression and protein kinase C activation. Cell Growth Differ. 5, 949-955.
32. Pérez, C., Vilaboa, N. E., García-Bermejo, L., De Blas, E., Creighton, A. M. and Aller, P. (1997). Differentiation of U-937 promonocytic cells by etoposide and lCRF-193. two antitumour DNA topoisomerasc II inhibitors with different mechanisms of action. J. Cell Sci. 110, 337-343.
33. Pérez-Sala, D., Collado-Escobar, D. and Mollinedo, F. (1995). Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells. through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 270, 6235-6242.
34. Reed, J. C. ( 1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
35. Rydel, R. E. and Greene, L. A. (1988). cAMP analogs promote survival neurite outgrowth in cultures of rat sympathetic and sensory neuro independently of nerve growth factor. Proc. Nat. Acad. Sci. USA 85, 1251-1261.
36. Sawai, H., Okazaki, T., Yamamoto, H., Okano, H., Takeda, Y., Tashima M., Sawada, H., Okuma, M., Ishikura, H., Unehara, H. and Domae (1995). Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270, 27326-27331.
37. Shenolikar, S. (1994). Protein serine/threonine phosphatases - new ave for cell regulation. Annu. Rev. Cell Biol. 10, 55-86.
38. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bisonnette, R. P. and Green, D. R. (1992). Role for c-myc in the in activation-induced apopt cell death in T cell hybridomas. Science 257, 212-214.
39. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, Ishikawa, F., Takaku, F., Yazaki, Y. and Hirai, H. (1992). Frequence mutations in the p53 gene in human myeloid leukemia cell lines. Blood 2378-2383.
40. Vilaboa, N. E., Calle, C., Pérez, C., De Blas, E., García- Bermejo, L. and Aller, P. (1995). cAMP increasing agents prevent the stimulation of he shock protein 70 (HSP70) gene expression by cadmium chloride in human myeloid cell lines. J. Cell Sci. 108, 2877-2883.
41. Vilaboa, N. E., García-Bermejo, L., Pérez, C., De Blas, E., Calle, C. and Aller, P. (1997). Heat-shock and cadmium chloride increase the vim mRNA and protein levels in U-937 human promonocytic cells. J. cells 110, 201-207.
42. Watabe, M., Masuda, Y., Nakajo, S., Yoshida, T., Kuroiwa, Y. and Nab M. (1996). The cooperative interaction of two different signaling pat in response to bufalin induces apoptosis in human leukemia U937 cells Biol. Chem. 24, 14067-14073.
43. Zanzami, N., Philippe, M., Castedo, M., Zanin, C., Vayssière, J. L., P. X. and Kroemer, G. (1995) Reduction in mitochondrial po constitutes an early irreversible step of programmed lymphocyte de vivo. J. Exp. Med. 181, 1661-1672.